Science Explorer Back to mapMap
Discussion
Company · Hershey · United States

Targepeutics (United States)

Research works
4
▲ 270% vs 2018-21
Citations
5
1.2 per fractional work
Top-10% rate
8.5%
all institutions 10.0%
Open access
88%
world 40%
International
9%
world 18%

Not ranked overall: Targepeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Targepeutics (United States) work in?

In all years, 56% of research at Targepeutics (United States) is in Health Sciences, 41% in Life Sciences. Its largest fields are Medicine (56%), Immunology and Microbiology (26%), Biochemistry, Genetics and Molecular Biology (15%). It does 1.3× the world's share of Health Sciences.

Life Sciences41%Physical Sciences3%Health Sciences56%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 4 fields, with their numbers
    1. Medicine256.4%
    1. Immunology and Microbiology125.6%
    2. Biochemistry, Genetics and Molecular Biology115.4%
    1. Materials Science02.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Targepeutics (United States)?

The most cited paper from Targepeutics (United States) is "IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma" (Julian S. Rechberger, Kendra A. Porath, Liang Zhang et al., 2022), with 13 citations. Next come "Targeting IL-13Rα2 for effective treatment of malignant peripheral nerve sheath tumors in mouse models" (7) and "Radiotherapy plus neoadjuvant and concomitant IL-13Rα2-directed immunotoxin therapy for diffuse intrinsic pontine glioma" (2).

Most cited papers
#PaperReleasedCitations
1 IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma Julian S. Rechberger, Kendra A. Porath, Liang Zhang et al. · Pharmaceutics Open access 24 Apr 2022 13
2 Targeting IL-13Rα2 for effective treatment of malignant peripheral nerve sheath tumors in mouse models Oliver Mrowczynski, Russell A. Payne, Alexandre Jose Bourcier et al. · Journal of neurosurgery Open access 27 Feb 2019 7
3 Radiotherapy plus neoadjuvant and concomitant IL-13Rα2-directed immunotoxin therapy for diffuse intrinsic pontine glioma Julian S. Rechberger, Wouter J. F. Vanbilloen, Leo F. Nonnenbroich et al. · Communications Biology Open access 15 Jan 2026 2
4 Synthesis, Radiolabeling and Preclinical Evaluation of [89Zr]Zr-DFO-GB13 in Diffuse Midline Glioma Mouse Model Viktoria E. Krol, Aditya Bansal, Liang Zhang et al. · Nuclear Medicine and Biology Nov 2025 0
All 4 most cited papers, with filters and sorting

Which research topics does Targepeutics (United States) publish most on?

By volume in 2022-now: Toxin Mechanisms and Immunotoxins, Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations and HER2/EGFR in Cancer Research.

  1. 1 Toxin Mechanisms and Immunotoxins Immunology 1 works
  2. 2 Chronic Lymphocytic Leukemia Research Genetics 0 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  4. 4 HER2/EGFR in Cancer Research Oncology 0 works
  5. 5 Glioma Diagnosis and Treatment Genetics 0 works
  6. 6 CAR-T cell therapy research Oncology 0 works
  7. 7 Cancer Research and Treatments Biotechnology 0 works
  8. 8 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  9. 9 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
  10. 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available87.5%not open12.5%

World: 40% of research is openly available.

with international co-authors8.8%domestic only91.2%

World: 18% is written across borders.

How has Targepeutics (United States)'s research output changed?

Output in 2022-2025 was 270% higher than in 2018-2021.

still counting20202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Hershey

All research institutions in Hershey

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Targepeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.